40 results on '"Gallia, Francesca"'
Search Results
2. Prospective open- label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.
3. High-dose immunoglobulin pulse therapy and risk of Covid19 infection
4. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
5. Idiopathic Chronic Immune-Mediated Neuropathies: Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy
6. Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Related Disorders
7. The circular RNA landscape in multiple sclerosis: Disease-specific associated variants and exon methylation shape circular RNA expression profile
8. High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy
9. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open‐label trial
10. Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP
11. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
12. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis
13. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP
14. Multifocal Motor Neuropathy: Current Therapies and Novel Strategies
15. Chronic inflammatory demyelinating polyradiculoneuropathy: Can we make a diagnosis in patients not fulfilling electrodiagnostic criteria?
16. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
17. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy
18. Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Related Disorders
19. Chronic motor axonal neuropathy
20. High-dose immunoglobulin pulse therapy and risk of Covid19 infection
21. Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy
22. Home monitoring of maintenance intravenous immunoglobulin therapy in patients with chronic inflammatory neuropathy
23. Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy
24. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
25. Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome
26. Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan
27. Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis
28. Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies
29. Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy
30. Insights on the role of private and public actors in food assistance provision: A literature review for High Income Countries.
31. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP
32. Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation
33. Frequency and Time to Relapse after Discontinuing 6-month Therapy with Intravenous Immunoglobulin or Methylprednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (P7.002)
34. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
35. Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update
36. Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation.
37. Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome.
38. A Randomized, Double Blind, Controlled Trial of Intravenous Immunoglobulins Versus Intravenous Methylprednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (IMC Study)
39. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis
40. High-dose immunoglobulin pulse therapy and risk of Covid19 infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.